We are proud to present to you during this World Congres of Thyroid Cancer the FLUOBEAM®, which is able to identify parathyroid glands by autofluorescence but also their perfusion, real bonus and gain in the prevention of the post-operative complications. Come to discover or to rediscover with our application engineers the various applications of the FLUOBEAM® on the booth 12.
Thyroid and parathyroid surgery are two common surgical procedures that have become very safe thanks to the surgical advances. However, hypoparathyroidism remains the current concern of thyroid surgery.
New fluorescence imagining techniques, have been developed to help the detection of parathyroid glands and confirm their vascularization. This has opened a new exciting area of research for surgeons and scientists.
Moreover, our fluorescence imagining system FLUOEAM® has received the market authorization from FDA to help in real-time localization of parathyroid tissue during procedures such as thyroidectomy or parathyroidectomy.
In this context, we are delighted to see you at this first international symposium and to present to you our fluorescence imaging solutions and their various applications.
We also invite you to our symposium presented by Mrs. Odile ALLARD the CEO of Fluoptics© and Mr. Philippe RIZO the CTO of Fluoptics©, which is based on the latest Fluoptics© innovations. This symposium will take place on February 28th from 6 to 7 pm.
Last November FLUOPTICS receives the market authorization from FDA for FLUOBEAM® to detect parathyroid tissue in real time during surgery.
It is a recognition of the performance of the FLUOBEAM® and for the development of fluorescence imaging.
Today, we are highlighted in the Presences revue of the Grenoble CCI for this market authorization.
For more information, please click on the link Présences_CCI de Grenoble.
As every year, the surgical association of endocrinology, CAEK, gathered to exchange on various themes of the endocrinology, the scientific discoveries in molecular biology and the cooperation between different medical specialization. This 37th congress will study the current results of endocrine surgery theses and also on the clinical and scientific questions of the patient prognosis and his quality of life for thyroid surgery, the parathyroid glands, adrenal and pancreatic.
For this congress we shall be delighted to meet you on our booth to present to you our FLUOBEAM® that you could test. Be the first to discover our latest application dedicated to the thyroid and parathyroid glands surgery.
Identification of parathyroid glands may be challenging during thyroid and parathyroid surgery. Accidental resection of the glands may increase the morbidity of the surgery. The aim of this study was to evaluate accuracy in identification of autofluorescent parathyroid glands with the use of near infrared light in real time.